RT Book, Section
A1 Dvorak, Christopher C.
A1 Auletta, Jeffery J.
A2 Kline, Mark W.
SR Print(0)
ID 1182933719
T1 Fever and Infection in the Immunocompromised Patient
T2 Rudolph's Pediatrics, 23e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9781259588594
LK accesspediatrics.mhmedical.com/content.aspx?aid=1182933719
RD 2024/04/25
AB A  key  element  in  the  effective  care  of  immunocompromised  patients  with  fever  is  hypervigilance.  Not  only  are  these  patients  at  increased  risk  for  a  diverse  range  of  microorganisms,  but  also  infections  caused  by  these  organisms  can  present  in  subtle  or  atypical  ways  and  often  progress  to  difficult-to-treat  chronic  disease  states  or  rapid  clinical  decompensation.  Therefore,  empiric  anti-infective  therapy  is  justified  for  new-onset  fever  in  immunocompromised  patients  while  a  thorough  investigation  into  the  source  of  fever  is  performed.  Because  antimicrobial  therapies  often  have  adverse  side  effects,  an  accurate  evaluation  to  guide  definitive  antimicrobial  therapy  becomes  crucial.